Congenital toxoplasmosis: An overview of the neurological and ocular manifestations
K Khan, W Khan - Parasitology International, 2018 - Elsevier
Toxoplasma gondii is an obligate intracellular parasite which is known to infect one-third of
the total world population chronically though it is asymptomatic in immunocompetent patients…
the total world population chronically though it is asymptomatic in immunocompetent patients…
Omicron BA. 4/BA. 5 escape neutralizing immunity elicited by BA. 1 infection
K Khan, F Karim, Y Ganga, M Bernstein, Z Jule… - Nature …, 2022 - nature.com
SARS-CoV-2 Omicron (B.1.1.529) BA.4 and BA.5 sub-lineages, first detected in South Africa,
have changes relative to Omicron BA.1 including substitutions in the spike receptor binding …
have changes relative to Omicron BA.1 including substitutions in the spike receptor binding …
Intersectionality in student movements: Black queer womxn and nonbinary activists in South Africa's 2015–2016 protests
K Khan - Agenda, 2017 - Taylor & Francis
This research attempts to capture and contextualise a historical moment among black queer
womxn and gender nonbinary activists involved with the 2015–2016 student protests at the …
womxn and gender nonbinary activists involved with the 2015–2016 student protests at the …
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
The emergence of the SARS-CoV-2 variant of concern Omicron (Pango lineage B.1.1.529),
first identified in Botswana and South Africa, may compromise vaccine effectiveness and …
first identified in Botswana and South Africa, may compromise vaccine effectiveness and …
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
…, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan… - Nature, 2022 - nature.com
The SARS-CoV-2 Omicron variant (B.1.1.529) has multiple spike protein mutations 1 , 2 that
contribute to viral escape from antibody neutralization 3 , 4 , 5 – 6 and reduce vaccine …
contribute to viral escape from antibody neutralization 3 , 4 , 5 – 6 and reduce vaccine …
Escape of SARS-CoV-2 501Y. V2 from neutralization by convalescent plasma
SARS-CoV-2 variants of concern (VOC) have arisen independently at multiple locations 1 ,
2 and may reduce the efficacy of current vaccines that target the spike glycoprotein of SARS-…
2 and may reduce the efficacy of current vaccines that target the spike glycoprotein of SARS-…
[HTML][HTML] SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
The emergence of SARS-CoV-2 Omicron, first identified in Botswana and South Africa, may
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
[PDF][PDF] Coronavirus RNA proofreading: molecular basis and therapeutic targeting
F Robson, KS Khan, TK Le, C Paris, S Demirbag… - Molecular cell, 2020 - cell.com
The coronavirus disease 2019 (COVID-19) that is wreaking havoc on worldwide public health
and economies has heightened awareness about the lack of effective antiviral treatments …
and economies has heightened awareness about the lack of effective antiviral treatments …
[PDF][PDF] SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape
Characterizing SARS-CoV-2 evolution in specific geographies may help predict properties
of the variants that come from these regions. We mapped neutralization of a SARS-CoV-2 …
of the variants that come from these regions. We mapped neutralization of a SARS-CoV-2 …
Evolution and neutralization escape of the SARS-CoV-2 BA. 2.86 subvariant
Omicron BA.2.86 subvariant differs from Omicron BA.2 as well as recently circulating variants
by over 30 mutations in the spike protein alone. Here we report on the isolation of the live …
by over 30 mutations in the spike protein alone. Here we report on the isolation of the live …
